{"id":"W2014836885","doi":"10.1111/tbj.12284","title":"Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression-Free Survival on First-Line Therapy Predicts Overall Survival Impact","year":2014,"lang":"en","type":"article","venue":"The Breast Journal","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"Roche Canada","keywords":"Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Docetaxel; Breast cancer; Chemotherapy; Retrospective cohort study; Paclitaxel; Cohort; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00386799,0.0006189782,0.0009497955,0.0002495887,0.0009945368,0.0002612353,0.0009166886,0.0001648681,0.0008243945],"category_scores_gemma":[0.0003032042,0.0003294871,0.0005568225,0.0003879946,0.0003548504,0.0002576828,0.0001561465,0.001432172,0.0000238658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008982863,"about_ca_system_score_gemma":0.001050002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002280757,"about_ca_topic_score_gemma":0.0001354038,"domain_scores_codex":[0.9939649,0.0008619567,0.0007667761,0.0005782114,0.00252903,0.001299184],"domain_scores_gemma":[0.9957485,0.001023571,0.0005087922,0.0009220958,0.0008991931,0.0008978421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05309163,0.004075756,0.05669877,0.0004458981,0.002655898,0.0002510373,0.001927721,0.000686502,0.001919104,0.0004684453,0.02099864,0.8567806],"study_design_scores_gemma":[0.04469654,0.02033336,0.882493,0.006420643,0.0007811496,0.01962457,0.0003505017,0.008620626,0.002522788,0.005953515,0.006962195,0.001241061],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8966479,0.002909482,0.002538125,0.08285029,0.002563529,0.006253747,0.003308912,0.0002459461,0.002682031],"genre_scores_gemma":[0.9931616,0.0009651403,0.0005751277,0.0004410401,0.003957788,0.0003113796,0.00008381918,0.0001843603,0.0003198117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8555395,"threshold_uncertainty_score":0.9999157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03977329334124006,"score_gpt":0.3970839875597167,"score_spread":0.3573106942184766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}